After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Exercise
Calculated transaction value
$420K

Behbahani Ali Director

Transaction date Sep 17, 2026
Public filing date Sep 21, 2026
Filing lag Filed 4 days later

CRSP daily price context

Close on/before transaction
$57.33 Sep 17, 2026
First close after public filing
$59.03 Sep 22, 2026
30-day return after filing
-14.45% Through Oct 21, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Shares
Quantity / price
30,000 shares @ $14
SEC ownership
Direct
Transaction code
M
Form
4
Filing identifier
0001193125-26-396944
Filing cohort

Transactions in this filing

Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.2M
Buys / sales
0 / 1
Transactions reported in the same official filing
Issuer Transaction Traded Value
Crispr Therapeutics Ag CRSP Sale Sep 17, 2026 $780.94K
Crispr Therapeutics Ag CRSP Exercise Sep 17, 2026 $0
Crispr Therapeutics Ag CRSP Current Exercise Sep 17, 2026 $420K